Vaginal cream for dryness: what it is and how well it works

What is vaginal cream for dryness, and who is it for?

Vaginal cream for dryness is for women who have dryness, painful sex or urinary symptoms at menopause and in the years after it. It sits among the menopause treatments and can be a first choice or a later one.

These symptoms are grouped under one name, genitourinary syndrome of menopause, or GSM; older writing may call it vaginal atrophy. GSM covers dryness, discomfort, painful sex, urgency and repeated UTIs, which tend to get worse over time without treatment (The Menopause Society, 2022). That is one reason to know the options early, even for a woman who chooses to wait.

Estrogen is not the only approach. Pelvic floor training sits beside it for vaginal and urinary health at this stage (The Menopause Society, 2022), and the non-hormonal products are set out in the evidence below. These are not either-or choices, and a doctor, nurse or pharmacist can say which suits the symptom that bothers you most.

Does vaginal estrogen work, and is it safe?

The evidence supports vaginal estrogen for dryness, painful sex and urinary symptoms, and the need is wide. About half of women (~50%) have dryness, painful sex, urgency or repeated UTIs around menopause (The Menopause Society, 2022). The North American Menopause Society's 2020 GSM statement, as reported in its press release, gives a range instead of a single number: roughly 27% to 84% of postmenopausal women. The two figures describe different things. The first is one summary figure for four named symptoms; the second covers GSM as a whole among postmenopausal women, and a range that wide means there is no single agreed number. About half sits inside it, so the figures are consistent, though neither is exact.

That 2020 statement sets out treatment in steps. For milder symptoms the first line is non-hormonal: lubricants, used during sex, and long-acting vaginal moisturizers (moisturisers in the UK). The prescription options are low-dose vaginal estrogen, vaginal DHEA inserts and oral ospemifene. Moving to a prescription does not mean leaving the first step behind: lubricants and moisturizers help alongside vaginal estrogen too (The Menopause Society, 2022).

The reason given for long-term use is that very little of the estrogen reaches the bloodstream, so most women can keep using it, often alongside HRT (The Menopause Society, 2022). That page is for women also weighing hormone therapy for the wider symptoms of menopause. This is a position taken in guidance; the cream trial described below ran for 12 weeks, so it cannot confirm safety over years.

On 10 November 2025 the FDA announced that it would remove the black box warning from estrogen therapy labels, including low-dose vaginal estrogen, according to the American Urological Association, which describes low-dose vaginal estrogen as safe and effective. Women who have read that warning on a leaflet may find this useful context for a conversation with a doctor or pharmacist. In the UK, the NHS information on vaginal oestrogen is the equivalent place to look.

How much vaginal estrogen is used, and how often?

A cream is placed inside the vagina in a small measured amount. In the 2018 phase 3 trial of estradiol cream, that amount was 0.5 g of 0.003% cream, which contains 15 µg of estradiol. It was used daily for the first 2 weeks and then twice weekly.

That pattern, a daily start followed by a twice-weekly routine, is the one with trial evidence behind it for this cream. Other creams, and the tablet, pessary, gel and ring forms the NHS lists, carry their own doses, so the directions that come with a given product are the guide. A pharmacist can explain how they compare with the trial schedule.

Access differs by country. In the US, low-dose vaginal estrogen is a prescription treatment; in the UK, where it is called vaginal oestrogen, the NHS says it is prescription-only apart from two products a pharmacy can sell without a prescription.

For the wider picture, our page on how to treat vaginal dryness sets the estrogen option alongside the others, for readers who would like to compare them before deciding.

What did the studies show, and what did they not show?

The 2018 phase 3 trial, published in the Journal of Women's Health, was a randomized controlled trial in postmenopausal women whose most bothersome symptom was vaginal dryness. On the trial's dryness score, women using estradiol 0.003% cream improved by 1.4 points and women using a placebo cream improved by 1.2 (p=0.013).

In plain terms, both groups felt better, and the estrogen added a modest further gain on top of what a plain cream did. The p-value says that extra gain is unlikely to be chance; it does not say the gain is large. The clearer separation was in a measured sign: vaginal pH fell by 1.26 with estradiol and by 0.31 with placebo.

What the trial did not show is worth knowing too. It tested one cream at one strength and did not compare the cream with tablets, pessaries or rings, so it cannot rank the forms or say what happens over years. It also says less about women whose main symptom is urinary, such as urgency or repeated UTIs.

A woman whose medical history raises questions about using estrogen may find it helpful to talk the choice through with her doctor before starting.

Next steps

A good place to start is to note which symptoms bother you most, such as dryness, painful sex or urinary urgency, and how long they have been present. You might then raise them with your doctor (your GP in the UK), a nurse or a pharmacist, and ask whether a moisturizer, a lubricant or low-dose vaginal estrogen fits best. If any of the signs to see a doctor about on this page apply to you, it's worth booking that visit sooner. Some women start with non-hormonal options and some begin with estrogen, and many change course as their symptoms change. This is not one size fits all, and the choice that fits your body, your history and your preferences is yours to make.